Literature DB >> 18303998

Protein tyrosine phosphatases in autoimmunity.

Torkel Vang1, Ana V Miletic, Yutaka Arimura, Lutz Tautz, Robert C Rickert, Tomas Mustelin.   

Abstract

Protein tyrosine phosphatases (PTPs) are important regulators of many cellular functions and a growing number of PTPs have been implicated in human disease conditions, such as developmental defects, neoplastic disorders, and immunodeficiency. Here, we review the involvement of PTPs in human autoimmunity. The leading examples include the allelic variant of the lymphoid tyrosine phosphatase (PTPN22), which is associated with multiple autoimmune diseases, and mutations that affect the exon-intron splicing of CD45 (PTPRC). We also find it likely that additional PTPs are involved in susceptibility to autoimmune and inflammatory diseases. Finally, we discuss the possibility that PTPs regulating the immune system may serve as therapeutic targets.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18303998     DOI: 10.1146/annurev.immunol.26.021607.090418

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN: 0732-0582            Impact factor:   28.527


  81 in total

1.  Identification and validation of inhibitor-responsive kinase substrates using a new paradigm to measure kinase-specific protein phosphorylation index.

Authors:  Xiang Li; Varsha Rao; Jin Jin; Bin Guan; Kenna L Anderes; Charles J Bieberich
Journal:  J Proteome Res       Date:  2012-06-18       Impact factor: 4.466

Review 2.  Historical overview of immunological tolerance.

Authors:  Ronald H Schwartz
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-04-01       Impact factor: 10.005

3.  microRNAs at the regulatory frontier: an investigation into how microRNAs impact the development and effector functions of CD4 T cells.

Authors:  Erik Allen Lykken; Qi-Jing Li
Journal:  Immunol Res       Date:  2011-04       Impact factor: 2.829

Review 4.  Detecting shared pathogenesis from the shared genetics of immune-related diseases.

Authors:  Alexandra Zhernakova; Cleo C van Diemen; Cisca Wijmenga
Journal:  Nat Rev Genet       Date:  2009-01       Impact factor: 53.242

5.  In silico screening for PTPN22 inhibitors: active hits from an inactive phosphatase conformation.

Authors:  Shuangding Wu; Massimo Bottini; Robert C Rickert; Tomas Mustelin; Lutz Tautz
Journal:  ChemMedChem       Date:  2009-03       Impact factor: 3.466

6.  GLEPP1/protein-tyrosine phosphatase phi inhibitors block chemotaxis in vitro and in vivo and improve murine ulcerative colitis.

Authors:  Rosanna Pescini Gobert; Monique van den Eijnden; Cedric Szyndralewiez; Catherine Jorand-Lebrun; Dominique Swinnen; Linfeng Chen; Corine Gillieron; Fiona Pixley; Pierre Juillard; Patrick Gerber; Caroline Johnson-Léger; Serge Halazy; Montserrat Camps; Agnes Bombrun; Margaret Shipp; Pierre-Alain Vitte; Vittoria Ardissone; Chiara Ferrandi; Dominique Perrin; Christian Rommel; Rob Hooft van Huijsduijnen
Journal:  J Biol Chem       Date:  2009-02-20       Impact factor: 5.157

Review 7.  [Relevance of the gene variant PTPN22 620W for rheumatology].

Authors:  I Melchers; P Ahnert
Journal:  Z Rheumatol       Date:  2008-11       Impact factor: 1.372

Review 8.  CD45, CD148, and Lyp/Pep: critical phosphatases regulating Src family kinase signaling networks in immune cells.

Authors:  Michelle L Hermiston; Julie Zikherman; Jing W Zhu
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

9.  Gold(I) phosphine mediated selective inhibition of lymphoid tyrosine phosphatase.

Authors:  Mark R Karver; Divya Krishnamurthy; Nunzio Bottini; Amy M Barrios
Journal:  J Inorg Biochem       Date:  2009-12-28       Impact factor: 4.155

10.  Role of PTP/PTK trans activated insulin-like signalling pathway in regulation of grasshopper (Oedaleus asiaticus) development.

Authors:  Babar Hussain Chang; Boyang Cui; Hidayat Ullah; Shuang Li; Kun Hao; Xiongbing Tu; Guangjun Wang; Xiangqun Nong; Mark Richard McNeill; Xunbing Huang; Zehua Zhang
Journal:  Environ Sci Pollut Res Int       Date:  2019-01-31       Impact factor: 4.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.